Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 7,040.00
-170.00 (-2.36%)
At close: Sep 3, 2026
Biodyne Market Cap
Biodyne has a market cap or net worth of 204.57 billion as of September 4, 2026. Its market cap has decreased by -50.91% in one year.
Market Cap
204.57B
Enterprise Value
189.82B
Revenue
5.77B
Ranking
n/a
PE Ratio
161.64
Stock Price
7,040.00
ChartMarket Cap Chart
Since March 17, 2021, Biodyne's market cap has decreased from 252.12B to 204.57B, a decrease of -18.86%. That is a compound annual growth rate of -3.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 207.52B | -48.36% |
| Dec 30, 2025 | 401.82B | -16.15% |
| Dec 30, 2024 | 479.20B | 19.24% |
| Dec 28, 2023 | 401.88B | 185.76% |
| Dec 29, 2022 | 140.63B | -31.74% |
| Dec 30, 2021 | 206.02B | -18.28% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Livsmed | 832.65B |
| Curiox Biosystems | 832.64B |
| M.I.TECH Co.,Ltd | 166.36B |
| BIOBIJOU | 164.74B |
| Celemics | 159.90B |
| Synergy Innovation | 139.65B |
| RecensMedical | 107.36B |
| Corentec | 53.56B |